Dynatrace Beats Q2, Raises FY27 Revenue Outlook, Adds $1B Buyback
DT sits 50% above its 52-week low of $31.635.
Summary
Dynatrace beat Q2 FY27 estimates and raised full-year revenue and ARR guidance, while absorbing about 150 basis points of Arize-related margin dilution. The board added a new $1 billion buyback authorization, lifting total remaining repurchase capacity to roughly $1.3 billion.
Key Events · Earnings and Guidance · DT
-
Q2 Beat on Top and Bottom Line
Total revenue of $579.9 million rose 17% year-over-year and non-GAAP EPS came in at $0.54 versus $0.44 a year ago; total ARR reached $2,207 million, up 16%.
-
FY27 Revenue Guidance Raised
Full-year ARR guidance midpoint rose $34 million to $2,393-$2,413 million and revenue midpoint rose $22 million to $2,330-$2,340 million, reflecting about 200 basis points of ARR accretion from Arize.
-
Margin and EPS Guidance Cut on Arize
FY27 non-GAAP operating margin guidance fell about 150 basis points to 28%-28.25% and non-GAAP EPS guidance dropped $0.09 to $1.88-$1.90, reflecting 175 basis points of Arize dilution.
-
New $1 Billion Buyback Authorized
The board authorized an incremental $1 billion repurchase program, bringing total remaining capacity to approximately $1.3 billion; Dynatrace spent $246 million buying back 5.2 million shares at an average $47.38 in Q2.
Analysis · DT · Technology
Dynatrace beat the September quarter (non-GAAP EPS $0.54 on $580M revenue, up 17%) and lifted full-year revenue and ARR guidance, but the raise comes with a cost: the Arize acquisition pushes FY27 non-GAAP operating margin guidance down about 150 basis points to 28%-28.25% and non-GAAP EPS down $0.09 to $1.88-$1.90. The board also authorized an incremental $1 billion buyback, taking total remaining capacity to roughly $1.3 billion — real support for the share count after $246 million of repurchases in the quarter at an average $47.38. The tension for investors is growth-plus-buyback versus margin compression from the deal.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DT was trading at $47.50 on NYSE in the Technology sector, with a market capitalization of approximately $15.9B. The 52-week trading range was $31.64 to $66.30. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.